Oligonucleotide Chemistry & Therapeutics Symposium14 September 2022 | BST (UTC+1)

An intensive 1-day meeting that delves into the latest in oligonucleotides chemistry, process & analytical development, therapeutics, antisense therapy & a meeting place for experts working within cutting-edge oligo research & therapeutic development.

Our Symposiums are delivered through Swapcard, our market-leading and highly interactive digital event platform. Alongside the live programme, it has a variety of other features to maximise your event experience, including AI-assisted match-making with other delegates, additional resource such as white papers, exhibitor pages allowing you to connect with leading solution providers and a host of On-Demand content.

Download Agenda
Full details on the symposium, including the presentations, topic areas and confirmed speakers can be found in the conference brochure
Book Online
Full Registration for the Oligonucleotide Chemistry & Therapeutics Symposium now open. Please click the button below to register for this event.
LinkedIn Group

Our LinkedIn group aims to foster discussion and collaboration between experts working in proteins, bispecifics, peptides and oligonucleotides

Programme

Oligonucleotide Chemistry & Therapeutics Symposium includes...

Attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions working within Oligonucleotides

  • Hear from and meet with the leading figures in the oligonucleotides chemistry, formulation & delivery, development and therapeutics; offering in-depth presentations and new ideas you can use to advance your research
  • Interact with fellow attendees and speakers through in-depth panel discussions and workshops as well as live speaker Q&As
  • Explore case studies pertaining to how oligonucleotides are used in therapeutics
  • Gain a comprehensive understanding of the latest synthesis technologies & analytical development

Agenda at a Glance

Track 1 – Oligo Chemistry, Formulation & Delivery AI/Machine Learning

  • Advanced synthesis technologies
  • Oral delivery of oligos
  • Purification technology development:
         » Freeze-drying
         » Chromatography
  • Impurity analysis

Track 2 – Oligo Therapeutics

  • Case studies from:
         » Oncology
         » Genetic disorders
         » Cardiovascular diseases
         » Rare diseases
  • miRNA therapeutics
  • Antisense oligonucleotide therapeutics

Confirmed Speakers

The Symposium brings together a panel of prominent leaders, engineers and scientists sharing new case studies, innovative data and industry outlook for the future

Below were some of the key speakers of our Virtual Symposium: Oligonucleotides: Chemistry & Therapeutics 2021 Event 

michael keller

Michael Keller

F.Hoffman-La Roche Ltd
chandra-vargeese

Chandra Vargeese

Wave Life Sciences

Punit_Seth

Punit Seth

Ionis Pharmaceuticals

Shalini Andersson

Shalini Andersson

AstraZeneca

Tomas Leek

Tomas Leek

AstraZeneca

Event Features​

Networking and knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual, remote experiences. 

Virtual Presentations

Benefit from the insight of our expert speakers via live and pre-recorded presentations

Live Q&As

Interact with fellow attendees and speakers during the live Q&As at the end of each presentation

Digital Networking Opportunities

Connect directly with other registrants of event around the world

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Waters Corporation

Event Sponsor

 For over sixty years, Waters Corporation has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.  

Waters Corporation, holds worldwide leading positions in complementary analytical technologies – liquid chromatography, mass spectrometry, rheometry, and microcalorimetry.  

Specifically, the company designs, manufactures, sells, and services UltraPerformance Liquid Chromatography (UPLC), high performance liquid chromatography (HPLC), chromatography columns and chemistry products, mass spectrometry (MS) systems, thermal analysis, and rheometry instruments 

Waters Division creates business advantages for laboratory-dependent organizations by delivering practical and sustainable scientific innovation to enable significant advancement in healthcare delivery, environmental management, food safety, and water quality. Waters Division products are used by pharmaceutical, life science, biochemical, industrial, academic, and government organizations working in research and development, quality assurance, and other laboratory applications. Waters UPLC, HPLC, and MS instruments and consumables are used in a broad range of industries to measure the chemical, physical, and biological composition of materials.  

https://www.waters.com/waters/en_US/Biopharmaceutical-Analysis/nav.htm?cid=134528454&locale=en_US&xcid=ad-o_08621 

 

ST Pharma Co Ltd

Business Developer Sponsor

ST Pharm is a subsidiary company of Dong-A Socio Group, Korea’s top pharmaceutical company with a history of 80 years. ST Pharm operates fully integrated services, including CRO and CDMO business, which allows one-stop service from pre-clinical stage to commercialisation. The main business of ST Pharm is API CDMO business and producing now more than 40 pipelines of excellent quality APIs through our ample knowledge and accumulated know-hows. The expansion of production capabilities in the production of oligonucleotides became a new growth engine for the future. In particular, the establishment of Oligonucleotide Plant in 2018 has secured our place in the Global Top 3 oligonucleotide production company. In 2020, ST Pharm has launched new manufacturing business for mRNA vaccines and therapeutics and the decision has been made to compete for preoccupancy of rapidly growing global mRNA vaccine markets.  

Bio Works

Event Sponsor

Bio-Works is the home of WorkBeads™, innovative and advanced agarose-based chromatography resins. We supply resins for purification of a broad range of biomoleculein research, process development or at manufacturing scale and our products are used in academic research laboratories, biopharmaceutical companies and many more areas. WorkBeads resins are manufactured using a proprietary method that results in outstanding purity, high binding capacity and high flow rates.   

Bio-Works’ site for R&D, manufacturing and supply is located in Fyrislund, Uppsala, a place strongly associated with chromatography. Our staff have a wealth and depth of experience in developing and using resins for separation and purification, allowing us to innovate for the best of the industry. We provide customers with tailored solutions and put their needs at the heart of what we do.